Alliancebernstein L.P. Fibrogen Inc Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.38 - $0.91 $3,838 - $9,191	-10,100 Reduced 13.23%	66,250 $58,000
Q3 2023 Nov 14, 2023	SELL	$0.79 - $2.83 $26,575 - $95,201	-33,640 Reduced 30.58%	76,350 $65,000
Q2 2023 Aug 15, 2023	SELL	$2.49 - $20.59 $534,391 - $4.42 Million	-214,615 Reduced 66.12%	109,990 $296,000
Q1 2023 May 15, 2023	SELL	$15.95 - $25.18 $7.4 Million - $11.7 Million	-464,133 Reduced 58.85%	324,605 $6.06 Million
Q4 2022 Feb 14, 2023	BUY	$13.27 - $17.73 $1.96 Million - $2.62 Million	147,750 Added 23.05%	788,738 $12.6 Million
Q3 2022 Nov 15, 2022	BUY	$11.4 - $14.6 $5.93 Million - $7.6 Million	520,298 Added 431.1%	640,988 $8.34 Million
Q1 2022 May 13, 2022	BUY	$12.02 - $16.79 $90,150 - $125,925	7,500 Added 6.63%	120,690 $1.45 Million
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $97,314 - $150,822	-9,800 Reduced 7.97%	113,190 $1.6 Million
Q1 2021 May 06, 2021	BUY	$31.0 - $55.72 $24,800 - $44,576	800 Added 0.65%	122,990 $4.27 Million
Q4 2020 Feb 08, 2021	SELL	$37.09 - $48.97 $3.71 Million - $4.9 Million	-100,000 Reduced 45.01%	122,190 $4.53 Million
Q3 2020 Nov 12, 2020	BUY	$40.47 - $45.5 $910,575 - $1.02 Million	22,500 Added 11.27%	222,190 $9.14 Million
Q2 2020 Aug 13, 2020	BUY	$32.57 - $42.83 $1.04 Million - $1.37 Million	31,900 Added 19.01%	199,690 $8.09 Million
Q1 2020 May 14, 2020	BUY	$23.3 - $45.96 $1.2 Million - $2.37 Million	51,500 Added 44.29%	167,790 $5.83 Million
Q4 2019 Feb 18, 2020	BUY	$34.58 - $48.06 $13,832 - $19,224	400 Added 0.35%	116,290 $4.99 Million
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $33,282 - $43,605	900 Added 0.78%	115,890 $4.29 Million
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $274,014 - $433,134	7,800 Added 7.28%	114,990 $5.2 Million
Q1 2019 May 14, 2019	BUY	$42.83 - $59.91 $38,547 - $53,919	900 Added 0.85%	107,190 $5.83 Million
Q4 2018 Feb 13, 2019	BUY	$37.97 - $60.16 $22,782 - $36,096	600 Added 0.57%	106,290 $4.92 Million
Q2 2018 Aug 13, 2018	SELL	$44.9 - $64.95 $2.16 Million - $3.13 Million	-48,140 Reduced 31.29%	105,690 $6.62 Million
Q1 2018 May 14, 2018	BUY	$45.35 - $61.65 $398,173 - $541,287	8,780 Added 6.05%	153,830 $7.11 Million
Q3 2017 Nov 13, 2017	BUY	$33.4 - $53.9 $4.84 Million - $7.82 Million	145,050	145,050 $7.8 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account